Eastgate Biotech Corp.
ETBI
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -121.38% | 24.92% | -67.27% | -20.26% | -0.40% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.15% | -116.85% | 750.39% | 1,931.58% | -- |
| Change in Net Operating Assets | -57.45% | 298.85% | -46.13% | -61.01% | -- |
| Cash from Operations | -915.65% | -7.82% | 28.06% | -146.99% | 176.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 3,747.24% | -73.17% | 10.51% | 23.56% | -- |
| Total Debt Repaid | -43.36% | -- | -- | 84.29% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 667.51% | 20.07% | 11.46% | 31.34% | -- |
| Foreign Exchange rate Adjustments | -100.00% | 368.47% | -126.75% | 888.10% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -206.50% | 644.09% | -- | -100.00% | 197.71% |